There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Exhibition > FREE Symposium: Detecting SARS-CoV-2 with qPCR
  1. FREE Symposium: Detecting SARS-CoV-2 with qPCR

    1. Tuesday, September 8, 2020,11:00 AM - 2:00 PM, Eastern Standard Time
    2. Online
    3. Stephen Bustin, PhD; Jim Huggett, PhD; Mikael Kubista, PhD
    We are sponsoring The-Scientist Symposium: Detecting SARS-CoV-2 with qPCR
  2. ACROBiosystems is sponsoring the Symposium!

    Event Overview

    SARS-CoV-2 has put unprecedented pressure on medical professionals, public health organizations, and the general public. The accurate and timely diagnosis of SARS-CoV-2 infection is paramount to controlling the spread of this virus. This, in turn, relies on the establishment of well-validated testing and detection measures to ensure rapid result dissemination without sacrificing sensitivity and specificity.

    This virtual symposium, brought to you by The Scientist, will explore the limitations and challenges of current SARS-CoV-2 qPCR-based testing approaches, their root causes, and what can be learned for the future.


    Symposium program

    11:00 AM – Basic considerations for SARS-CoV-2 testing by RT-qPCR
    Stephen Bustin, PhD


    The advent of qPCR was quickly accompanied by questions on how best to validate and standardize the data produced. In this talk, Dr. Bustin will address qPCR sensitivity, specificity, and efficiency, as well as comment on data robustness and how to best approach qPCR data for analysis and comparison purposes.

    11:40 AM – Current standards and validations for SARS-CoV-2 testing
    Jim Huggett, PhD


    SARS-CoV-2 arrived in the different regions of the world at different times and in differing magnitudes. As such, SARS-CoV-2 testing responses have been somewhat varied. Dr. Huggett will speak on the current QA/QC standards for qPCR-based SARS-CoV-2 testing, discuss the limitations and challenges that have been encountered with regard to testing validation and standardization, and explore the root causes for these issues.

    12:20 PM – Learning from a pandemic: How do we do it better?
    Mikael Kubista, PhD


    SARS-CoV-2 may be unparalleled in impact, but it is far from the first—or last—pandemic to afflict the world. Here, Dr. Kubista will discuss the lessons to be learned from the preparations and responses to SARS-CoV-2 made by various nations, governments, and health entities across the world, as well as the necessary preparations for future waves of SARS-CoV-2 and for future pandemics.

    1:00 PM – Open Panel Q&A Session


    Bustin, Huggett, and Kubista will be joined by colleagues Jo Vandesompele and Michael Pfaffl in an open question and answer session where they will address questions posed by the audience.


    Meet the speakers:

    图片2.pngStephen A. Bustin, PhD
    Professor of Molecular Medicine
    Faculty of Health, Education, Medicine and Social Care
    Anglia Ruskin University

    图片3.pngJim F. Huggett, PhD
    Senior Lecturer, Analytical Microbiology
    School of Biosciences and Medicine
    University of Surrey

    图片4.pngMikael Kubista, PhD
    Head, Institute of Biotechnology
    Czech Academy of Sciences
    Founder and Chairman of the Board
    TATAA Biocenter

    图片5.pngJo Vandesompele, PhD
    Department of Biomolecular Medicine
    Faculty of Medicine and Health Sciences
    Ghent University

    图片6.pngMichael W. Pfaffl, PhD
    Professor of Molecular Physiology
    Animal Physiology & Immunology
    School of Life Sciences
    Technical University of Munich

New & Hot Products

This web search service is supported by Google Inc.